Clinical Trials Directory

Trials / Completed

CompletedNCT06623942

Prostasin Levels in Preeclamptic Women

Prostasin Levels in Preeclampsia: A Comparative Study With Healthy Pregnancies

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Başakşehir Çam & Sakura City Hospital · Other Government
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study will aim to compare maternal serum prostasin levels between women diagnosed with preeclampsia and healthy normotensive pregnant controls. Participants will be divided into two main groups: those with preeclampsia and those with uncomplicated pregnancies. The preeclampsia group will further be subdivided based on the severity of the condition. Maternal serum samples will be collected from all participants, and prostasin levels will be measured using ELISA. Statistical analyses will be performed to evaluate whether prostasin levels are significantly elevated in the preeclampsia group, particularly in those with severe features, and to assess its potential as a biomarker for the condition.

Conditions

Timeline

Start date
2023-01-01
Primary completion
2024-01-01
Completion
2024-03-01
First posted
2024-10-02
Last updated
2024-10-02

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06623942. Inclusion in this directory is not an endorsement.